Search results
Brokerage Radar: NBFC, Bank stocks in focus; Indegene gets sell call, Polycab rated overweight
CNBC Awaaz· 16 hours agoDiscover the latest brokerage calls and analyst insights on active stocks and sectors today, including updates on the NBFC sector and individual stocks like Yes Bank, Indegene, and Polycab.
Trade setup for Thursday: Top 15 things to know before the opening bell
CNBC Awaaz· 1 day agoIf the Nifty 50 manages to hold 24,200, then 24,500 can't be ruled out in the coming sessions. Until...
FIIs net buy equities worth Rs 5,484 crore, DIIs net sell shares worth Rs 924 crore
CNBC Awaaz· 1 day agoDIIs bought Rs 14,121 crore worth of shares and sold shares worth Rs 15,046 crore. Meanwhile, FIIs...
Sensex top performers, losers during the 70k-80k journey
CNBC Awaaz· 1 day agoAnalysts say India is experiencing a mini-Goldilocks moment with strong macros: 8.2% GDP growth in...
Sensex, Nifty post record closing highs as bank, metal stocks shine; VIX falls 3%
CNBC Awaaz· 1 day agoBenchmark indices Nifty and Sensex had closed the trading session at record highs after a sharp...
Taking Stock: Market hits new milestone; bank, metal, power outshine
CNBC Awaaz· 1 day agoAmong sectors, except media, all other sectoral indices ended in the green with power, capital...
Who is Keir Starmer tipped to win UK elections? A football buff who dragged Labour Party from left...
Indian Express· 1 day agoAs the United Kingdom heads for national elections on Thursday, July 4, the spotlight is on Keir...
ICICI Lombard hits new record high on CLSA upgrade, forecasts 7% upside potential
CNBC Awaaz· 1 day agoCLSA upgraded ICICI Lombard to 'outperform' from 'hold' and raised target price to Rs 2,000 per...
Get ready for higher brokerage charges under Sebi's new diktat
CNBC Awaaz· 2 days agoThe capital market diktat of levying uniform exchange fee on all broking firms irrespective of the...
Subscribe Emcure Pharmaceuticals Ltd; KR Choksey
CNBC Awaaz· 2 days agoKR Choksey, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.